GAMBARO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 9.096
EU - Europa 8.037
AS - Asia 4.145
AF - Africa 45
SA - Sud America 30
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.384
Nazione #
US - Stati Uniti d'America 9.071
CN - Cina 2.276
GB - Regno Unito 1.937
SG - Singapore 1.533
RU - Federazione Russa 1.171
IE - Irlanda 1.076
FR - Francia 1.051
IT - Italia 709
SE - Svezia 693
DE - Germania 511
FI - Finlandia 420
UA - Ucraina 325
VN - Vietnam 53
JP - Giappone 40
BE - Belgio 36
IN - India 35
KR - Corea 33
TG - Togo 33
HK - Hong Kong 32
PK - Pakistan 28
ID - Indonesia 27
AU - Australia 22
TR - Turchia 22
CA - Canada 20
NL - Olanda 20
BR - Brasile 19
IL - Israele 15
GR - Grecia 13
RO - Romania 10
IR - Iran 9
CH - Svizzera 8
ES - Italia 8
SK - Slovacchia (Repubblica Slovacca) 7
AT - Austria 6
NO - Norvegia 6
PL - Polonia 6
CL - Cile 5
DK - Danimarca 5
NZ - Nuova Zelanda 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
EU - Europa 4
MX - Messico 4
TH - Thailandia 4
BD - Bangladesh 3
EE - Estonia 3
EG - Egitto 3
HR - Croazia 3
IQ - Iraq 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
SA - Arabia Saudita 3
TN - Tunisia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MA - Marocco 2
MY - Malesia 2
NG - Nigeria 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CO - Colombia 1
CY - Cipro 1
JO - Giordania 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 21.384
Città #
Jacksonville 2.015
Southend 1.757
Chandler 1.325
Singapore 1.197
Dublin 1.074
Woodbridge 754
Ashburn 665
Houston 470
Lawrence 417
Princeton 417
Ann Arbor 405
Beijing 397
Wilmington 369
Jinan 216
Nanjing 175
Shenyang 151
New York 137
Sindelfingen 136
Verona 133
Hebei 113
Redmond 93
Tianjin 92
Helsinki 87
Seattle 83
Milan 74
Nanchang 69
Changsha 64
Zhengzhou 63
Ningbo 62
Boardman 60
Haikou 60
Norwalk 58
Guangzhou 50
Taizhou 50
Taiyuan 44
Jiaxing 42
Redwood City 42
Santa Clara 39
Fairfield 38
Brussels 36
Tokyo 36
Lomé 33
Hangzhou 32
Dallas 27
Hong Kong 26
Lanzhou 26
Dong Ket 25
Lancaster 25
Chicago 24
Fuzhou 24
Dongguan 23
Falls Church 23
Moscow 22
Kent 19
Martellago 19
Washington 19
Bologna 18
Jakarta 18
Seoul 18
Los Angeles 17
Mianwali 17
San Diego 17
Hyderabad 15
Shenzhen 15
Florence 14
London 14
Munich 14
San Francisco 14
Tappahannock 14
Genova 13
Toronto 13
Rome 12
Venice 12
Dearborn 11
Düsseldorf 11
Lappeenranta 10
Saint Petersburg 10
Shanghai 10
Auburn Hills 8
Cambridge 8
Edinburgh 8
Mehlingen 8
Phoenix 8
Sommacampagna 8
Amsterdam 7
Bonndorf 7
Catanzaro 7
Paris 7
Pisa 7
Bratislava 6
Detroit 6
Frankfurt am Main 6
Fremont 6
Madrid 6
Malda 6
Oslo 6
Padova 6
Radeberg 6
Trento 6
Warsaw 6
Totale 14.388
Nome #
Common Variants Associated to Type 2 Diabetes in the Italian Population 377
Placche di Randall e calcolosi ossalo-calcica idiopatica: quale ruolo e quale futuro? 204
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 171
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 171
Age dependence of within-subject biological variation of nine common clinical chemistry analytes 132
A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans. 108
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 108
mTOR inhibitors and renal allograft: Yin and Yang. 106
Sulodexide and glycosaminoglycans in the progression of renal disease. 104
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 100
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 98
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 97
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 97
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 96
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 94
Increased glomerular alpha 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment. 91
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 91
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 90
ADVANCES IN REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION ANALYSIS OF CELLULAR mRNA LEVELS OF TRANSFORMING GROWTH FACTOR-BETA1 BY CAPILLARY ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE DETECTION. 89
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 89
A validated model of disease progression in IgA nephropathy. 88
LIVER-KIDNEY-TRANSPLANTATION IN TYPE 1 PRIMARY HYPEROXALURIA: DESCRIPTION AND COMMENTS ON A CASE. 88
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 88
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 88
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): A Padua Medical School discovery in the 1930s. 87
QUANTITATION OF TGF-BETA1 mRNA IN PORCINE MESANGIAL CELLS BY COMPARATIVE KINETIC RT/PCR: COMPARISON WITH RIBONUCLEASE PROTECTION ASSAY AND IN SITU HYBRIDIZATION. 87
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 87
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 86
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 86
Renin-angiotensin system (RAS) DNA polymorphisms and TGFbeta1-mediated fibrogenetic pathway gene expression studies in primary IgA naphropathy (Berger’s disease). 85
Placche di Randal e calcolosi ossalocalcica idiopatica: quale ruolo e quale futuro? 85
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 85
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 85
Low-molecular-weight heparin prevents high glucose- and phorbol ester-induced TGF-beta 1 gene activation. 84
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. 84
Does Randall’s plaque represent a necessary condition in the pathogenesis of the idiopathic calcium oxalate stones? 84
Directional dominance on stature and cognition in diverse human populations. 84
Bone Disease in Medullary Sponge Kidney and Effect of Potassium Citrate Treatment. 83
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 83
The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy. 82
Detection of a large deletion in the P-selectin (SELP) gene 82
Medullary sponge kidney: state of the art. 82
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 82
Glycosaminoglycan therapy for long-term diabetic complications? 81
Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. 81
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 81
Randall's plaque, calcium-sensing receptor, and idiopathic calcium nephrolithiasis 81
Dietary fatty acid supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis. 80
Call for prospective studies of cystatin C. 80
Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders 80
Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients. 79
Lithiasis in cystic kidney disease and malformations of the urinary tract. 79
General practitioners' serum creatinine recording styles. 79
Predictive model for delayed graft function based on easily available pre-renal transplant variables 79
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 79
SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function 79
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 79
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 79
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 79
Inhibition of transforming growth factor-beta 1 gene overexpression as a strategy to prevent fibrosis. 78
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 78
Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. 77
ABNORMAL ARACHIDONIC ACID CONTENT OF MEMBRANE PHOSPHOLIPIDS- THE UNIFYING HYPOTHESIS FOR THE GENESIS OF HYPERCALCIURIA AND HYPEROXALURIA IN IDIOPATHIC CALCIUM NEPHROLITHIASIS. 77
Primary IgA nephropathy is more severe in TGF-ss1 high secretor patients 77
The Role of prEoperative ultraSonography on patenCy of native arteriovenoUs accEss: RESCUE Study (in press) 76
Unusual renal presentation of Fabry disease in a female patient. 76
Renal Stones in Medullary Sponge Kidney: Effect of Treatment with Alkali Citrate and Recognition of two Clinical Phenotypes. 76
Donor-transmitted cancer in kidney transplant recipients: a systematic review 76
Association studies of genetic polymorphisms and complex disease. 75
Henoch-Schonlein purpura and Crohn's disease in a family. 75
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 75
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 75
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 75
Silent chronic kidney disease epidemic seen from Europe: designing strategies for clinical management of the early stages. 74
Placche di Randall, familiarità per calcolosi e numerosità di eventi litiasici: esiste una correlazione ? 74
Heparanase as a target in cancer therapy. 74
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits 74
GLYCOSAMINOGLYCAN PREVENTS HYPERGLYCEMIA-INDUCED RENAL TGF-BETA 1 GENE EXPRESSION. 73
Crystals, Randall's plaques and renal stones: do bone and atherosclerosis teach us something? 72
Mild tubular damage induces calcium oxalate crystalluria in a model of subtle hyperoxaluria: Evidence that a second hit is necessary for renal lithogenesis. 72
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. 72
Invecchiamento e funzionalità renale: indagine prospettica in una coorte di soggetti anziani in buone condizioni di salute 71
Modulation of genetic associations with serum urate levels by body-mass-index in humans. 71
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study 71
GAPDH as housekeeping gene at renal level. 70
Identification of GDNF gene sequence variations in patients with medullary sponge kidney disease. 70
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 70
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 70
Small effective population size and genetic homogeneity in the Val Borbera isolate 69
Identification of a novel splice site mutation of CLCN5 gene and characterization of a new alternative 5' UTR end of ClC-5 mRNA in human renal tissue and leukocytes. 69
Citrate therapy in Dent's disease. 69
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. 69
Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. 69
GLUT-1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy. 68
LOW-MOLECULAR-WEIGHT HEPARIN PREVENTS HIGH GLUCOSE- AND PHORBOL ESTER-INDUCED TGF-BETA 1 GENE ACTIVATION. 68
Risk for renal failure in nephrolithiasis. 67
Liver-kidney-transplantation in type 1 primary hyperoxaluria: description and comments on a case. 67
Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues. 67
Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes 67
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial. 66
Totale 8.702
Categoria #
all - tutte 94.912
article - articoli 88.741
book - libri 0
conference - conferenze 3.149
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.022
Totale 189.824


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.547 0 0 0 0 83 421 125 162 77 191 81 407
2020/20212.784 307 395 65 320 377 376 35 203 161 32 372 141
2021/20222.210 109 498 12 194 75 27 38 187 107 113 138 712
2022/20234.960 494 381 676 609 536 1.278 27 277 445 30 138 69
2023/20242.874 105 226 247 232 277 404 73 559 27 90 386 248
2024/20252.896 481 577 277 1.295 266 0 0 0 0 0 0 0
Totale 21.931